Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-21-003410
Filing Date
2021-02-11
Accepted
2021-02-11 17:29:23
Documents
58

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 2260192
2 ex23-1.htm EX-23.1 3907
3 s-1_001.jpg GRAPHIC 7111
4 img_005.jpg GRAPHIC 122365
5 img_006.jpg GRAPHIC 38429
6 img_003.jpg GRAPHIC 20507
7 img_004.jpg GRAPHIC 17302
  Complete submission text file 0001493152-21-003410.txt   5479672

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE ptix-20200930.xml EX-101.INS 603537
9 XBRL SCHEMA FILE ptix-20200930.xsd EX-101.SCH 50029
10 XBRL CALCULATION FILE ptix-20200930_cal.xml EX-101.CAL 45751
11 XBRL DEFINITION FILE ptix-20200930_def.xml EX-101.DEF 190359
12 XBRL LABEL FILE ptix-20200930_lab.xml EX-101.LAB 333513
13 XBRL PRESENTATION FILE ptix-20200930_pre.xml EX-101.PRE 253200
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-253006 | Film No.: 21621144
SIC: 7389 Services-Business Services, NEC